Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors

作者: Alina Iulia Chiriac , Florian Kloss , Jonas Krämer , Cuong Vuong , Christian Hertweck

DOI: 10.1093/JAC/DKV161

关键词:

摘要: OBJECTIVES The spread of MDR bacteria represents a serious threat to human society and novel antibiotic drugs, preferably from new chemical classes, are urgently needed. Closthioamide was isolated the strictly anaerobic bacterium Clostridium cellulolyticum belongs class natural products, polythioamides. Here, we investigated antimicrobial activity mechanism action closthioamide. METHODS For assessing closthioamide, MIC values killing kinetics were determined. To identify its target pathway, whole-cell-based assays used including analysis macromolecular synthesis recording susceptibility profile library clones with down-regulated potential genes. Subsequently, inhibitory effect closthioamide on enzymes, e.g. DNA gyrase topoisomerase IV, evaluated. RESULTS had broad-spectrum against Gram-positive bacteria. Notably, very potent MRSA VRE strains. impaired replication inhibited activity, in particular ATPase function whereas there little cleavage-rejoining function. also relaxation gyrase, which does not require ATP hydrolysis, thus may allosterically rather than directly interfere gyrase. Cross-resistance ciprofloxacin novobiocin could be detected experimental mutants clinical isolates. CONCLUSIONS Closthioamide, member an unprecedented antibiotics, is inhibitor bacterial gyrase; however, molecular differs that quinolones aminocoumarins.

参考文章(49)
Christopher Walsh, Molecular mechanisms that confer antibacterial drug resistance Nature. ,vol. 406, pp. 775- 781 ,(2000) , 10.1038/35021219
M. A. Fischbach, C. T. Walsh, Antibiotics For Emerging Pathogens Science. ,vol. 325, pp. 1089- 1093 ,(2009) , 10.1126/SCIENCE.1176667
Ruth H. Flatman, Alison J. Howells, Lutz Heide, Hans-Peter Fiedler, Anthony Maxwell, Simocyclinone D8, an Inhibitor of DNA Gyrase with a Novel Mode of Action Antimicrobial Agents and Chemotherapy. ,vol. 49, pp. 1093- 1100 ,(2005) , 10.1128/AAC.49.3.1093-1100.2005
Florian Kloss, Thorger Lincke, Christian Hertweck, Highly Efficient Total Synthesis of the Clostridium-Derived anti-MRSA Antibiotic Closthioamide European Journal of Organic Chemistry. ,vol. 2011, pp. 1429- 1431 ,(2011) , 10.1002/EJOC.201001695
Claudia Sissi, Manlio Palumbo, In front of and behind the replication fork: bacterial type IIA topoisomerases Cellular and Molecular Life Sciences. ,vol. 67, pp. 2001- 2024 ,(2010) , 10.1007/S00018-010-0299-5
Frédéric Collin, Shantanu Karkare, Anthony Maxwell, Exploiting bacterial DNA gyrase as a drug target: current state and perspectives Applied Microbiology and Biotechnology. ,vol. 92, pp. 479- 497 ,(2011) , 10.1007/S00253-011-3557-Z
Andreas Reiner, Dirk Wildemann, Gunter Fischer, Thomas Kiefhaber, Effect of Thioxopeptide Bonds on α-Helix Structure and Stability Journal of the American Chemical Society. ,vol. 130, pp. 8079- 8084 ,(2008) , 10.1021/JA8015044
Huimin Wang, Yong Mao, Allan Y. Chen, Nai Zhou, Edmond J. LaVoie, Leroy F. Liu, Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry. ,vol. 40, pp. 3316- 3323 ,(2001) , 10.1021/BI002786J
David J. Newman, Gordon M. Cragg, Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010 Journal of Natural Products. ,vol. 75, pp. 311- 335 ,(2012) , 10.1021/NP200906S